Corona Remedies IPO: Complete Guide to Date, Price, Allotment & Investment Review 2025
Corona Remedies IPO is now open for subscription. The pharma company brings strong financial performance and growth potential in the healthcare segment. Investors can apply under retail, NII, and QIB categories and track live subscription updates, GMP trends, allotment status, and listing news on IPO JI